It is a concern that factors previously reported as being secreted by MPM cells, such as FGF2, HGF, PDGF-AA and VEGF [7, 87] validated poorly across patient-derived and commercial mesothelioma cell lines in our study (Fig. 1A and Supplementary Fig. 2D). The gene discussed is HGF; the disease is mesothelioma.